AI assistant
Sending…
MADRIGAL PHARMACEUTICALS, INC. — Director's Dealing 2023
Jun 21, 2023
30608_dirs_2023-06-20_2753da05-06ad-445d-8904-a0eab8d4f134.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MADRIGAL PHARMACEUTICALS, INC. (MDGL)
CIK: 0001157601
Period of Report: 2023-06-15
Reporting Person: Levy Richard S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-06-15 | Common Stock | A | 1198 | $0.00 | Acquired | 10298 | Direct |
Footnotes
F1: Represents a grant of restricted stock units, which vest on June 15, 2024, provided the Reporting Person continues in service with the Issuer on such date.
More from MADRIGAL PHARMACEUTICALS, INC.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Feb 24
Annual Report
2026
Feb 19
Regulatory Filings
2026
Feb 19
Regulatory Filings
2026
Jan 30
Director's Dealing
2026
Jan 26